$EYEN
Eyenovia Inc

2018 Q2 Form 10-Q Financial Statement

#000114420418026716 Filed on May 09, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2018 Q1 2017 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $910.0K $1.340M $200.0K
YoY Change 313.64% 570.0%
% of Gross Profit
Research & Development $2.412M $2.094M $910.8K
YoY Change 220.8% 129.91%
% of Gross Profit
Depreciation & Amortization $0.00 $5.325K $6.992K
YoY Change -23.84%
% of Gross Profit
Operating Expenses $3.321M $3.432M $1.107M
YoY Change 239.96% 210.06%
Operating Profit -$3.321M -$3.432M -$1.107M
YoY Change 239.96% 210.06%
Interest Expense $0.00 $2.137K $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$3.320M -$3.430M -$1.110M
YoY Change 238.78% 209.01%
Income Tax
% Of Pretax Income
Net Earnings -$3.319M -$3.430M -$1.106M
YoY Change 239.86% 209.99%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$332.0K -$453.7K -$111.7K
COMMON SHARES
Basic Shares Outstanding 9.937M shares 9.937M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q2 2018 Q1 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $24.56M $27.60M
YoY Change
Cash & Equivalents $24.56M $27.60M $2.506M
Short-Term Investments
Other Short-Term Assets $240.0K $360.0K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $24.81M $27.96M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $16.48K $22.64K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00
YoY Change
Total Long-Term Assets $16.48K $22.64K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $24.81M $27.96M
Total Long-Term Assets $16.48K $22.64K
Total Assets $24.82M $27.98M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $723.0K $549.1K
YoY Change
Accrued Expenses $490.0K $540.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.280M $1.123M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.280M $1.123M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $1.280M $1.120M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$26.01M -$22.69M
YoY Change
Common Stock $1.000K $994.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $23.54M $26.86M
YoY Change
Total Liabilities & Shareholders Equity $24.82M $27.98M
YoY Change

Cashflow Statement

Concept 2018 Q2 2018 Q1 2017 Q1
OPERATING ACTIVITIES
Net Income -$3.319M -$3.430M -$1.106M
YoY Change 239.86% 209.99%
Depreciation, Depletion And Amortization $0.00 $5.325K $6.992K
YoY Change -23.84%
Cash From Operating Activities -$3.040M -$2.391M -$868.9K
YoY Change 192.31% 175.18%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $12.24K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00 -$12.24K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $25.09M $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 24.74M $0.00
YoY Change
NET CHANGE
Cash From Operating Activities -3.040M -2.391M -$868.9K
Cash From Investing Activities 0.000 $0.00 -$12.24K
Cash From Financing Activities 0.000 24.74M $0.00
Net Change In Cash -3.040M 22.35M -$881.1K
YoY Change 192.31% -2636.83%
FREE CASH FLOW
Cash From Operating Activities -$3.040M -$2.391M -$868.9K
Capital Expenditures $0.00 $0.00 $12.24K
Free Cash Flow -$3.040M -$2.391M -$881.1K
YoY Change 192.31% 171.35%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2018Q1 dei Trading Symbol
TradingSymbol
EYEN
CY2018Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9936771 shares
CY2018Q1 us-gaap Cash
Cash
27602069 USD
CY2017Q4 us-gaap Cash
Cash
5249511 USD
CY2018Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
358138 USD
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
37149 USD
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22635 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27960 USD
CY2018Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
0 USD
CY2017Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
328700 USD
CY2018Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
549138 USD
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
246384 USD
CY2018Q1 eyen Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
574259 USD
CY2017Q4 eyen Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
306263 USD
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1123397 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
552647 USD
CY2018Q1 us-gaap Assets Current
AssetsCurrent
27960207 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
5286660 USD
CY2018Q1 us-gaap Assets
Assets
27982842 USD
CY2017Q4 us-gaap Assets
Assets
5643320 USD
CY2018Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
49549244 USD
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24351138 USD
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22690793 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19261186 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
26859445 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
5090673 USD
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27982842 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5643320 USD
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
994 USD
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
257 USD
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2094095 USD
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
910841 USD
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1337649 USD
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
195951 USD
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
3431744 USD
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
1106792 USD
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3431744 USD
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1106792 USD
CY2018Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
2137 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
333555 USD
CY2018Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
400996 USD
CY2017Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-91435 USD
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
22352558 USD
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-881121 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5249511 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3387288 USD
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27602069 USD
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2506167 USD
CY2017Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
443 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-3429607 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-1106349 USD
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.45
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.49
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7561915 shares
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2266667 shares
CY2018Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5325 USD
CY2017Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6992 USD
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
650576 USD
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3337 USD
CY2018Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
302754 USD
CY2018Q1 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
464 USD
CY2017Q1 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2390945 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-868879 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24743503 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
320989 USD
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14979 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12242 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12242 USD
CY2018Q1 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
345497 USD
CY2017Q1 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
0 USD
CY2018Q1 eyen Working Capital Amount
WorkingCapitalAmount
26836810 USD
CY2018Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
24500000 USD
CY2018Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
27352069 USD
CY2017Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
4999511 USD
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1746291 shares
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4807788 shares
CY2018Q1 eyen Prepaid Research And Development Expenses
PrepaidResearchAndDevelopmentExpenses
34500 USD
CY2017Q4 eyen Prepaid Research And Development Expenses
PrepaidResearchAndDevelopmentExpenses
28932 USD
CY2018Q1 us-gaap Prepaid Insurance
PrepaidInsurance
309350 USD
CY2017Q4 us-gaap Prepaid Insurance
PrepaidInsurance
384 USD
CY2018Q1 eyen Prepaid Patent Expense
PrepaidPatentExpense
14288 USD
CY2018Q1 eyen Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
297913 USD
CY2017Q4 eyen Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
120455 USD
CY2018Q1 us-gaap Accrued Rent Current
AccruedRentCurrent
0 USD
CY2017Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
133000 USD
CY2018Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
89892 USD
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
41831 USD
CY2018Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
35211 USD
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
10977 USD
CY2018Q1 eyen Accrued Legal Expenses Current
AccruedLegalExpensesCurrent
54249 USD
CY2017Q4 eyen Accrued Legal Expenses Current
AccruedLegalExpensesCurrent
0 USD
CY2018Q1 eyen Accrued Expenses And Other Liabilities Currents
AccruedExpensesAndOtherLiabilitiesCurrents
574259 USD
CY2017Q4 eyen Accrued Expenses And Other Liabilities Currents
AccruedExpensesAndOtherLiabilitiesCurrents
306263 USD
CY2018Q1 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
1100000 USD
CY2018Q1 us-gaap Malpractice Loss Contingency Insurance Recoveries
MalpracticeLossContingencyInsuranceRecoveries
10000000 USD
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
6000000 shares
CY2018Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
6000000 shares
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
6000000 shares
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9936771 shares
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9936771 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2566530 shares
CY2017Q4 eyen Prepaid Patent Expense
PrepaidPatentExpense
7833 USD
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
650576 USD
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
3337 USD
CY2018Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2051922 USD
CY2018Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M12D
CY2018Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
90000000 shares
CY2018Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
6000000
CY2018Q1 eyen Net Proceeds From Issuance Of Common Stock
NetProceedsFromIssuanceOfCommonStock
2014000000 USD
CY2018Q1 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
1733333000000 USD
CY2018Q1 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
4640241 shares
CY2018Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25089000 USD
CY2017Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2018Q1 eyen Payment Of Accrued Issuance Costs
PaymentOfAccruedIssuanceCosts
-133000 USD
CY2017Q1 eyen Payment Of Accrued Issuance Costs
PaymentOfAccruedIssuanceCosts
0 USD
CY2018Q1 eyen Reduction In Additional Paid In Capitalstock Issuance Costs
ReductionInAdditionalPaidInCapitalstockIssuanceCosts
-195700 USD
CY2017Q1 eyen Reduction In Additional Paid In Capitalstock Issuance Costs
ReductionInAdditionalPaidInCapitalstockIssuanceCosts
0 USD
CY2018Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
27300000 USD
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
2211000 USD
CY2018Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
96994 USD
CY2017Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
0 USD
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2566530 shares

Files In Submission

Name View Source Status
0001144204-18-026716-index-headers.html Edgar Link pending
0001144204-18-026716-index.html Edgar Link pending
0001144204-18-026716.txt Edgar Link pending
0001144204-18-026716-xbrl.zip Edgar Link pending
eyen-20180331.xml Edgar Link completed
eyen-20180331.xsd Edgar Link pending
eyen-20180331_cal.xml Edgar Link unprocessable
eyen-20180331_def.xml Edgar Link unprocessable
eyen-20180331_lab.xml Edgar Link unprocessable
eyen-20180331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv492501_10q.htm Edgar Link pending
tv492501_ex31-1.htm Edgar Link pending
tv492501_ex31-2.htm Edgar Link pending
tv492501_ex32-1.htm Edgar Link pending
tv492501_ex32-2.htm Edgar Link pending